Previous Nav
Net Change on 28-04-2025
PersonalFN Rating
Category
Assets (Cr.)
Expense Ratio
Fund House
Launch Date
Benchmark
Minimum Investment (₹)
Minimum Addl Investment (₹)
Exit Load (%)
Minimum SIP Investment (₹)
Minimum STP Investment (₹)
Minimum SWP Investment (₹)
52 Week Low Nav (₹)
52 Week Low Nav Date
52 Week High Nav (₹)
52 Week High Nav Date
Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised
Sun Pharmaceutical Industries Limited
Divi's Laboratories Limited
Lupin Limited
Suven Pharmaceuticals Limited
Apollo Hospitals Enterprise Limited
Max Healthcare Institute Limited
Torrent Pharmaceuticals Limited
Aurobindo Pharma Limited
Mankind Pharma Limited
Alkem Laboratories Limited
Aster DM Healthcare Limited
Abbott India Limited
Neuland Laboratories Limited
Net Receivables / (Payables)
Granules India Limited
Dr. Reddy's Laboratories Limited
Wockhardt Limited
Healthcare Global Enterprises Limited
Supriya Lifescience Limited
Fortis Healthcare Limited
Sumitomo Chemical India Limited
FDC Limited
GlaxoSmithKline Pharmaceuticals Limited
Rainbow Childrens Medicare Limited
Orchid Pharma Limited
Caplin Point Laboratories Limited
JB Chemicals & Pharmaceuticals Limited
Gland Pharma Limited
Emcure Pharmaceuticals Limited
Sai Life Sciences Limited
Vijaya Diagnostic Centre Limited
Cipla Limited
Onesource Specialty Pharma Limited
Shilpa Medicare Limited
SRF Limited
UPL Limited
Linde India Limited
Sequent Scientific Limited
Strides Pharma Science Limited
Laurus Labs Limited
Pharmaceuticals & Drugs
Hospital & Healthcare Services
Pesticides & Agrochemicals
Miscellaneous
Chemicals
Industrial Gases & Fuels
Cash
Equity
ITI Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to ITI Mutual Fund. It was launched on 08-Nov-2021 and currently has an AUM of ₹213.78 crore. ITI Pharma & Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and Nifty Healthcare Index - TRI as secondary index.
The NAV of ITI Pharma & Healthcare Fund ended up ₹0.26(1.63%)yesterday to ₹16.0138.
Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and
The ITI Pharma & Healthcare Fund is managed by Dhimant Shah and Rohan Korde.
ITI House, 36, R K Shirodkar Marg, Parel Mumbai - 400 012